JSM2025
Back to all people

Huei Wang

Amgen, Inc.
1 appearance in the program

Sessions & presentations

Advancing Late Phase Trials: Embracing Innovative Design and Analysis Strategies
Presentation: Total events of composite endpoint as primary endpoint in cardiovascular outcome trials
Contributed Papers · Tue, Aug 5 , 2:00 PM
Co-Author
↑